// App-Quantinova.ai

6586 : Patient and treatment characteristics of emergency presentations due to immune-mediated toxicities.

Researchers

Presenter

  • Sharon Hyo-Eun Nahm

Principal Investigators

  • Richard Heywood

  • Sophia Callaghan

  • Patricio Serra-Bellver

  • Avinash Gupta

  • Tim Cooksley

  • Paul Lorigan

Medical Centers

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • The Christie Hospital, Manchester, United Kingdom

  • University of Manchester and The Christie NHS FT, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Pembrolizumab

  • Infliximab

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved